Additionally, IL-17 promoted the growth rate and tumorigenicity of human cervical tumors transplanted into athymic nude mice [85]; knockdown of the IL-17 receptor in 4T1 mouse mammary cancer cells decreased tumor growth in vivo [86]; and IL-17 depletion delays development of chemically induced papillomas [55]. The gene discussed is IL17A; the disease is breast cancer.